Company logo

GRTS - Gritstone bio, Inc.

NASDAQ -> Healthcare -> Biotechnology
EmeryVille, United States
Type: Equity

GRTS price evolution
GRTS
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Current assets
Cash $65.28 $30.78 $43.85 $49.2
Short term investments $16.29 $54.41 $73.12 $98.68
Net receivables $0.23 $0.3 $0.4 $0.57
Inventory
Total current assets $87.44 $90.82 $122.38 $154.76
Long term investments $5.29 $5.29 $5.29 $5.29
Property, plant & equipment $84.12 $89.86 $92.43 $35.98
Goodwill & intangible assets
Total noncurrent assets $90.33 $96.4 $100.25 $55.19
Total investments $21.58 $59.7 $78.41 $103.97
Total assets $177.77 $187.22 $222.62 $209.95
Current liabilities
Accounts payable $3.82 $4.26 $4.92 $5.97
Deferred revenue $2.35 $1.3 $2.82 $2.8
Short long term debt $6.9 $6 $4.84 $4.63
Total current liabilities $27.34 $23.38 $22.11 $24.67
Long term debt $97.87 $89.3 $90.55 $44.15
Total noncurrent liabilities $98.58 $89.85 $90.94 $44.4
Total debt $104.78 $95.3 $95.39 $48.78
Total liabilities $125.92 $113.23 $113.06 $69.07
Shareholders' equity
Retained earnings -$659.56 -$628.74 -$590.31 -$555.05
Other shareholder equity $0 -$0.05 -$0.13 -$0.05
Total shareholder equity $51.85 $73.98 $109.57 $140.88
(in millions $) 31 Dec 2023 31 Jan 2023 31 Dec 2021 31 Dec 2020
Current assets
Cash $65.28 $17.31 $104.57 $170.06
Short term investments $16.29 $116.39 $108.35 $1
Net receivables $0.23 $0.66 $1.39
Inventory
Total current assets $87.44 $182.88 $220.59 $175.39
Long term investments $5.29 $9.32 $10.62
Property, plant & equipment $84.12 $38.82 $44.54 $43.45
Goodwill & intangible assets
Total noncurrent assets $90.33 $57.88 $57.52 $46.18
Total investments $21.58 $125.71 $118.97 $1
Total assets $177.77 $240.75 $278.11 $221.57
Current liabilities
Accounts payable $3.82 $8.69 $4.23 $9.58
Deferred revenue $2.35 $5.13 $20.33 $11.7
Short long term debt $6.9 $5.29 $7.48 $5.87
Total current liabilities $27.34 $34.8 $39.96 $26.99
Long term debt $97.87 $19.35 $18.94 $19.23
Total noncurrent liabilities $98.58 $35.17 $22.06 $27.84
Total debt $104.78 $40.32 $26.42 $25.1
Total liabilities $125.92 $69.97 $62.02 $54.83
Shareholders' equity
Retained earnings -$659.56 -$521.07 -$401.38 -$326.3
Other shareholder equity $0 -$0.08 -$0.07
Total shareholder equity $51.85 $170.78 $216.09 $166.74
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Revenue
Total revenue $10.38 $1.56 $1.96 $2.44
Cost of revenue
Gross Profit $10.38 $1.56 $1.96 $2.44
Operating activities
Research & development $32.94 $32.76 $30.97 $30.51
Selling, general & administrative $7.92 $7.41 $6.72 $6.75
Total operating expenses $40.86 $40.17 $37.7 $37.26
Operating income -$30.48 -$38.61 -$35.75 -$34.82
Income from continuing operations
EBIT -$29.6 -$37.44 -$34.27 -$33.14
Income tax expense
Interest expense $1.22 $0.99 $0.98 $0.84
Net income
Net income -$30.82 -$38.43 -$35.26 -$33.98
Income (for common shares) -$30.82 -$38.43 -$35.26 -$33.98
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Revenue
Total revenue $16.34 $19.95 $48.21 $4.04
Cost of revenue
Gross Profit $16.34 $19.95 $48.21 $4.04
Operating activities
Research & development $127.18 $111.4 $97.49 $88.64
Selling, general & administrative $28.78 $28.97 $25.93 $21.41
Total operating expenses $156 $140.37 $123.42 $110.05
Operating income -$139.65 -$120.43 -$75.21 -$106.02
Income from continuing operations
EBIT -$134.45 -$118.45 -$75.08 -$105.31
Income tax expense
Interest expense $4.04 $1.24
Net income
Net income -$138.49 -$119.69 -$75.08 -$105.31
Income (for common shares) -$138.49 -$119.69 -$75.08 -$105.31
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Net income -$30.82 -$38.43 -$35.26 -$33.98
Operating activities
Depreciation $5.71 $5.48 $6.43 $4.04
Business acquisitions & disposals
Stock-based compensation $2.82 $2.96 $2.94 $2.89
Total cash flows from operations -$19.51 -$31.09 -$30.96 -$40.09
Investing activities
Capital expenditures -$0.19 -$1.09 -$1.72 -$1.57
Investments $38.49 $19.37 $26.31 $22.74
Total cash flows from investing $38.3 $18.28 $24.59 $21.17
Financing activities
Dividends paid
Sale and purchase of stock $5.86 $0.02 $1.1 $1.96
Net borrowings $9.86 -$0.08 -$0.08 $7.43
Total cash flows from financing $15.72 -$0.26 $1.02 $8.65
Effect of exchange rate
Change in cash and equivalents $34.5 -$13.07 -$5.35 -$10.27
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Net income -$138.49 -$119.69 -$75.08 -$105.31
Operating activities
Depreciation $21.65 $15.69 $14.4 $14.15
Business acquisitions & disposals
Stock-based compensation $11.62 $12.56 $10.55 $7.11
Total cash flows from operations -$121.65 -$115.95 -$50.68 -$89.1
Investing activities
Capital expenditures -$4.57 -$5.87 -$5.7 -$3.52
Investments $106.91 -$7.09 -$112.85 $69.46
Total cash flows from investing $102.34 -$12.96 -$118.55 $65.95
Financing activities
Dividends paid
Sale and purchase of stock $8.93 $65.51 $117.21 $135.91
Net borrowings $17.13 $18.48 -$8.45 -$0.1
Total cash flows from financing $25.12 $83.1 $108.76 $135.8
Effect of exchange rate
Change in cash and equivalents $5.81 -$45.81 -$60.47 $112.65
Fundamentals
Market cap $273.24M
Enterprise value $312.73M
Shares outstanding 97.59M
Revenue $16.35M
EBITDA -$112.80M
EBIT -$134.45M
Net Income -$138.49M
Revenue Q/Q 143.62%
Revenue Y/Y -18.04%
P/E ratio -1.97
EV/Sales 19.13
EV/EBITDA -2.77
EV/EBIT -2.33
P/S ratio 16.72
P/B ratio 5.27
Book/Share 0.53
Cash/Share 0.67
EPS -$1.42
ROA -69.46%
ROE -147.22%
Debt/Equity 2.43
Net debt/EBITDA -0.54
Current ratio 3.20
Quick ratio 3.20